Physiologic Assessment of Microvascular Function in Heart Transplant Patients — Stella

Clinical trial discovery in plain English. Data sourced from ClinicalTrials.gov.

About Browse conditions ClinicalTrials.gov ↗

Stella is not a medical provider and does not give medical advice. AI-generated summaries are for informational purposes only. Always consult your doctor before making any healthcare decisions.

Physiologic Assessment of Microvascular Function in Heart Transplant Patients — Stella

Home/Cardiac Allograft Vasculopathy/

View on ClinicalTrials.gov

Recruiting

Back to Cardiac Allograft Vasculopathy trials

Trial locations(1 site)

South Korea

Samsung Medical Center, Seoul

Key details

Sponsor

Samsung Medical Center

Enrollment target

~200 participants

Started

May 2016

Primary completion

June 2030

Age range

18 Years – 85 Years

Last updated March 2025

Interested in joining?

Tell us you're interested and we'll help connect you with the research team. We'll never share your email without your permission.

Your name

Email address

Stella acts as an intermediary. Researcher contact info is never exposed.

Follow this trial

Get notified in plain English when this trial's status changes. No account required.